Trial Profile
Phase 1 clinical study of F598 for the treatment of latent and new onset tuberculosis
Status:
Recruiting
Phase of Trial:
Phase I
Latest Information Update: 06 Aug 2018
Price :
$35
*
At a glance
- Drugs F-598 (Primary)
- Indications Tuberculosis
- Focus Adverse reactions
- 06 Aug 2018 New trial record